These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9706059)
1. Investigation of absorption kinetics by the phase plane method. Dokoumetzidis A; Macheras P Pharm Res; 1998 Aug; 15(8):1262-9. PubMed ID: 9706059 [TBL] [Abstract][Full Text] [Related]
2. The area function method for assessing the drug absorption rate in linear systems with zero-order input. Cheng H; Jusko WJ Pharm Res; 1989 Feb; 6(2):133-9. PubMed ID: 2762213 [TBL] [Abstract][Full Text] [Related]
3. A modified residual method to estimate the zero-order absorption rate constant in a one-compartment model. Liu X; Brouwer KL; Pollack GM Biopharm Drug Dispos; 1997 Mar; 18(2):93-101. PubMed ID: 9099446 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of controlled release formulations: estimation of the duration of the zero-order absorption and ascertainment of absorption kinetics. Macheras P Biopharm Drug Dispos; 1991 Apr; 12(3):173-87. PubMed ID: 2059669 [TBL] [Abstract][Full Text] [Related]
5. Drug Delivery and Transport into the Central Circulation: An Example of Zero-Order In vivo Absorption of Rotigotine from a Transdermal Patch Formulation. Cawello W; Braun M; Andreas JO Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):475-481. PubMed ID: 29332198 [TBL] [Abstract][Full Text] [Related]
6. An alternative method for the estimation of the terminal slope when a few data points are available. Dokoumetzidis A; Iliadis A; Macheras P J Pharm Sci; 1999 May; 88(5):557-60. PubMed ID: 10229649 [TBL] [Abstract][Full Text] [Related]
7. Theophylline. Pooled Michaelis-Menten parameters (Vmax and Km) and implications. Wagner JG Clin Pharmacokinet; 1985; 10(5):432-42. PubMed ID: 3899457 [TBL] [Abstract][Full Text] [Related]
8. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation. Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of plasma enfuvirtide after subcutaneous administration to patients with human immunodeficiency virus: Inverse Gaussian density absorption and 2-compartment disposition. Zhang X; Nieforth K; Lang JM; Rouzier-Panis R; Reynes J; Dorr A; Kolis S; Stiles MR; Kinchelow T; Patel IH Clin Pharmacol Ther; 2002 Jul; 72(1):10-9. PubMed ID: 12152000 [TBL] [Abstract][Full Text] [Related]
10. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption. George K Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411 [TBL] [Abstract][Full Text] [Related]
11. Absorption of theophylline from a sustained-release theophylline tablet formulation, Theo-Dur. Takagi K; Hasegawa T; Ogura Y; Yamaki K; Suzuki R; Satake T; Imaeda N; Mizukami Y Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):530-5. PubMed ID: 3429057 [TBL] [Abstract][Full Text] [Related]
12. Population Pharmacokinetic Analysis of the Oral Absorption Process and Explaining Intra-Subject Variability in Plasma Exposures of Imatinib in Healthy Volunteers. Golabchifar AA; Rezaee S; Dinan NM; Kebriaeezadeh A; Rouini MR Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):527-39. PubMed ID: 26189007 [TBL] [Abstract][Full Text] [Related]
13. Power law IVIVC: an application of fractional kinetics for drug release and absorption. Kytariolos J; Dokoumetzidis A; Macheras P Eur J Pharm Sci; 2010 Oct; 41(2):299-304. PubMed ID: 20599504 [TBL] [Abstract][Full Text] [Related]
14. Half-time analysis of the integrated Michaelis equation. Simulation and use of the half-time plot and its direct linear variant in the analysis of some alpha-chymotrypsin, papain- and fumarase-catalysed reactions. Wharton CW; Szawelski RJ Biochem J; 1982 May; 203(2):351-60. PubMed ID: 7115291 [TBL] [Abstract][Full Text] [Related]
15. Critical analysis of "flip-flop" phenomenon in two-compartment pharmacokinetic model. Byron PR; Notari RE J Pharm Sci; 1976 Aug; 65(8):1140-4. PubMed ID: 978432 [TBL] [Abstract][Full Text] [Related]
16. The maximum pharmacodynamic effect as a response parameter: pharmacokinetic considerations. Leopold CS J Pharm Pharmacol; 1999 Sep; 51(9):999-1008. PubMed ID: 10528981 [TBL] [Abstract][Full Text] [Related]
17. A method of determining the in vivo drug release rate constant of sustained-release preparation. Sun H; Chow MS Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910 [TBL] [Abstract][Full Text] [Related]